Bowman Spotlights: Three I've Mostly Moved On From
The flip side of writing up what I'm buying is being honest about what I'm selling. Three names I've trimmed or stopped adding to, and the specific reason on each. Moving on isn't the same as writing off, and the conviction behind each exit is different.
I'd rather tell you when I'm wrong, or when a thesis has cooled, than quietly let a position rot in the binder and pretend I still believe in it. These are three I was in on at one point and have stepped back from. One I've mostly sold, one I've trimmed, one I'm just done adding to. The data is doing the talking on all three.
Aidan Smith (TB, 21, OF)
This is the clearest exit on the list, and the advanced metrics confirmed what I was afraid of. Smith started late after a hamstring injury opened his season on the injured list, so it's only 114 plate appearances, but the line is brutal and it isn't a small-sample fluke: .192/.265/.242, a 37 wRC+, and the number that scares me most, a .051 isolated power with zero home runs. The reason I trust it is that it echoes last year. The power has simply vanished.
The scouting context makes it worse, not better. Smith came over as the headline piece in a notable trade, billed as a five-tool center fielder. The book now says he struggles badly with velocity, his hands don't get going in time, and both his hit and power grades have slid into the 40s. A 22.8% strikeout rate with a .250 BABIP says this isn't bad luck papering over good contact. It's the contact itself.
His Perf+ at High-A is 46.5. There's still the speed, and he's only 21, so I'm not calling him finished. But the bat has to show me something before I'd step back in.
The card: 2024 Bowman 1st auto, $16 raw, $87 in a PSA 10, and drifting down (was $22 a month ago). The worry: 37 wRC+, .051 ISO, zero homers, and a velocity hole the scouting reports now flag explicitly. My move: 75% sold. This is the one where the metrics matched my gut and I acted on it.
Kellon Lindsey (LAD, 20, SS)
Lindsey is the tricky one, and I want to be fair about the context. On the surface he's raking: .408/.494/.662 and a 187 wRC+. But that's 17 games, because the bigger story is that he can't stay on the field.
The thin sample isn't a slump dressed up, it's injuries. Lindsey lost most of 2025 to a throwing-shoulder impingement and then back problems that ended his year on the 60-day list, all of 32 games in his pro debut. He opened 2026 on the injured list too and only got going in mid-May. So I'm not dunking on the .408. It's genuinely encouraging that he's back and hitting. It's just 17 games, on a .578 BABIP that means almost nothing at that volume, with a 27% strikeout rate underneath that I'd want to watch. You can't prove a bat in twelve Low-A games, healthy or not.
The durability is the first worry, then the path. Lindsey is a 2024 first-rounder with 80-grade speed and the athleticism to play anywhere, but the Dodgers already have him off shortstop and mostly at second base, in deference to other infielders ahead of him in the system. Moving off short caps his value, and a deep org blocks the runway even if he stays healthy and hits. A trade out of Los Angeles would change this calculus quickly, and that's the scenario I'm holding the rest for.
The card: 2024 Bowman Draft 1st auto, $22 raw, $72 in a PSA 10, ticking back up since he returned. The worry: an injury history that's cost him two seasons of reps, plus a blocked path that caps the value even when the bat shows up. My move: 25% sold. Holding the rest as a trade lottery ticket. If he's dealt to a thinner system and stays healthy, I'm interested again.
Aroon Escobar (PHI, 21, 3B/2B)
This one stings a little, because I was out front on Escobar. I had him hyped as a higher-rated name in 2025 Bowman, and I still think the approach and the pedigree are real. He's a 21-year-old holding his own at Double-A, which is aggressive for the age, and the 9.8% walk rate plus 16 steals say the feel and athleticism haven't gone anywhere.
But the risks in the profile are showing. The season line at Double-A is .218/.302/.313, a 62 wRC+, with the power evaporating to a .095 ISO and just four homers. He's had hot stretches that spiked the card, but the full-sample read is a below-average bat right now. The scouting flags pile on: a body already softer than you'd want, lazy footwork that costs him range, and a likely move down the defensive spectrum that puts more pressure on the bat to carry the profile.
I'm not selling. There's still time, he hasn't looked awful, and a 21-year-old at Double-A with this approach can still figure it out. But the conviction that had me adding is gone. I'm holding what I have and letting it play out.
The card: 2025 Bowman 1st auto, $26 raw, $114 in a PSA 10, volatile but net down from the spring. The worry: .095 ISO power outage, a 62 wRC+ season line, and defensive questions pushing him toward a bat-only profile. My move: holding, but done buying. The hype call was mine, and I'm letting the position ride rather than doubling down.
The thread
Three exits, three different reasons. Smith is a metrics-confirmed sell, the one where I saw the warning and moved. Lindsey is a durability-and-path call, where a trade and a clean bill of health would flip me back. Escobar is a thesis that cooled, a name I championed and am now content to hold without adding.
None of this is a victory lap or a panic. It's just keeping the book honest. The names I'm buying ran in a separate piece; this is the other half of the same discipline.
Check the HobbyMonitor Prospect Dashboard for current Bowman 1st auto prices on all three.
This is not financial advice. These are cards. The data and analysis are here to inform. You make your own calls.
This article was generated with the assistance of AI and reviewed before publishing. Always verify latest market data, stats, or news.
Published: June 2026.